Medical News

RSS

c-Met could be a potential personalized target for metastatic HCC

Targeting c-Met may be a promising personalized treatment method for approximately 45 percent of patients with hepatocellular carcinoma (HCC) who have c-Met-positive tumors, according to study results presented at the Fourth AACR International Conference on Molecular Diagnostics in Cancer Therapeutic Development.

29 Sep 2010

USFDA approves Sun Pharmaceutical's ANDA to market Rilutek tablets

Sun Pharmaceutical Industries Ltd. announced that USFDA has granted a tentative approval for its Abbreviated New Drug Application (ANDA) to market a generic version of Sanofi Aventis's Rilutek® tablets 50 mg.

29 Sep 2010

Chelsea Therapeutics announces $35 million in shares in registered public offering

Chelsea Therapeutics International, Ltd. announced today its intention, subject to market and other conditions, to offer $35 million in shares of its common stock in a registered public offering pursuant to its existing shelf registration statement.

29 Sep 2010

National survey shows 60% of U.S. adults not familiar with sepsis

Sixty percent of U.S. adults are not familiar with sepsis, despite the fact that more than 200,000 Americans die from it every year, making sepsis one of the leading causes of death in the nation. Lack of awareness is even higher among adults over age 65, who are at greater risk of sepsis, according to a new national survey sponsored by The Feinstein Institute for Medical Research in Manhasset, NY, part of the North Shore–LIJ Health System.

28 Sep 2010

SCS, PNS prove to be effective tools in treating chronic pain: NANS, ASIPP

Afflicting countless people worldwide, chronic pain is a largely misunderstood and under-treated disease that forever alters the lives of more than 50 million Americans each year.

28 Sep 2010

IAPP Privacy Academy attendees to preview findings on healthcare, data privacy

Attendees at the International Association of Privacy Professionals Privacy Academy will preview early findings of The Ponemon Institute's latest research that examines healthcare providers' compliance with the HITECH Act data breach privacy provisions. They will also learn how to protect patients' medical privacy and how to comply with the latest regulations.

28 Sep 2010

PolyMedix begins PMX-30063 Phase 2 clinical trial for bacterial infections

PolyMedix, Inc., an emerging biotechnology company focused on developing new therapeutic drugs to treat acute cardiovascular disorders and infectious diseases, has initiated a Phase 2 clinical trial in Canada with its novel defensin-mimetic antibiotic, PMX-30063.

28 Sep 2010

Healthcare professionals need appropriate training, support to help people who self-harm: Research

Healthcare professionals are still not receiving the appropriate training and support they need to help people who self-harm and this can result in negative attitudes and inadequate levels of care.

28 Sep 2010

Oncolytics Biotech receives patent for modified reovirus variant

Oncolytics Biotech Inc. today announced that it has been granted U.S. Patent, 7,803,385 entitled Reoviruses Having Modified Sequences. The patent claims cover methods for making and using modified reoviruses, and pharmaceutical compositions that include modified reoviruses.

28 Sep 2010

HSR waiting period to acquire ZymoGenetics expires: Bristol-Myers Squibb

Bristol-Myers Squibb Company announced today that the Hart-Scott-Rodino (HSR) waiting period for its tender offer for ZymoGenetics, Inc. has expired.

28 Sep 2010

Study finds that 90% of EDs nationwide also offer preventive-care services

People go to emergency departments when they've broken a leg, been stabbed or otherwise need urgent care. But a new study from the Stanford University School of Medicine finds that 90 percent of EDs nationwide also offer preventive-care services.

28 Sep 2010

Endo Pharmaceuticals to acquire Qualitest Pharmaceuticals

Apax Partners today announced that Endo Pharmaceuticals has entered into a definitive agreement to acquire Qualitest Pharmaceuticals for approximately $1.2 billion in cash. Qualitest, a portfolio company of Apax Partners since 2007, is the sixth largest generic pharmaceutical company in the U.S.

28 Sep 2010

IsoRay reports increase revenue for 2010 fiscal year

IsoRay Inc. a medical isotope company and the exclusive manufacturer of Cesium-131 used in internal radiation therapy for the treatment of lung, colon, head and neck, and prostate cancers, ocular melanoma, and other malignant disease through the use of its proprietary radioisotope technology, announced its financial results for the year ended June 30, 2010.

28 Sep 2010

Neuronix to present TMS treatment trial data for Alzheimer's disease at Geneva Congress

The results of a successful clinical trial using Neuronix Ltd., a developer of a patent-pending, non-invasive system for Alzheimer's Disease and related conditions, will be presented for the first time today at the annual Congress of the European Federation of Neurological Societies in Geneva, Switzerland.

28 Sep 2010

$IOF report reveals poor state of post-fracture care in Russian Federation$

IOF report reveals poor state of post-fracture care in Russian Federation

Preliminary findings from an upcoming new report by the International Osteoporosis Foundation (IOF) show alarming projections and reveal the poor state of post-fracture care in the Russian Federation and many other countries in the region. The findings were announced today at a press conference in St. Petersburg at the IOF Summit of Eastern European and Central Asian Osteoporosis Patient Societies.

28 Sep 2010

Plackers joins OHA campaign to promote oral health awareness

Plackers, a leading brand of consumer oral care products, has partnered with Oral Health America, the nation's leading independent organization dedicated to eliminating oral disease through access, education and advocacy, on the Fall for Smiles program to promote oral health awareness nationwide.

28 Sep 2010

LSU receives NIH grant to strengthen biomedical research infrastructure

LSU has received a $15 million grant from the National Institutes of Health, or NIH, IDeA Networks of Biomedical Research Excellence, or INBRE, program. The grant is centered in the School of Veterinary Medicine, or SVM, and the Department of Biological Science in the LSU College of Science. The purpose of this five-year grant is to strengthen the biomedical research infrastructure and work force within Louisiana.

28 Sep 2010

New Formulary Forum reports market growth of immune biologics

HealthLeaders-InterStudy and Fingertip Formulary find that the market growth of immune biologics will come from the expansion of indications for immune biologics in response to limited off-label use and competition for preferred status.

28 Sep 2010

Researchers find genetic variants that cause arthritis in breast cancer patients taking aromatase inhibitors

Mayo Clinic researchers and their international colleagues have discovered genetic variants that lead to severe arthritis for a subset of women when taking aromatase inhibitors to treat their breast cancer. This serious side effect is so painful that many women halt their lifesaving medication. The findings appear today in the online issue of Journal of Clinical Oncology.

28 Sep 2010

NIH Stroke Scale helps to predict mortality risk in hospitalized stroke patients

A new study finds a risk model developed using Get With The Guidelines-Stroke data is a practical bedside tool that can identify patients at the highest risk for dying when hospitalized after a stroke.

28 Sep 2010